Literature DB >> 6143933

Absence of cross-reactivity between captopril and enalapril.

G J Navis, P E de Jong, C G Kallenberg, J de Monchy, D de Zeeuw.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143933     DOI: 10.1016/s0140-6736(84)92353-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Severe cutaneous reaction to captopril.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

2.  Cytolytic hepatitis with captopril but not with enalapril.

Authors:  F Zannad; P Y Marie; E Aliot; P Trechot; J M Gilgenkrantz
Journal:  Cardiovasc Drugs Ther       Date:  1988-03       Impact factor: 3.727

3.  Does captopril exacerbate psoriasis?

Authors:  N W Hamlet; M Keefe; R E Kerr
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-21

Review 4.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 5.  ACE inhibitor-induced angioedema. Incidence, prevention and management.

Authors:  W Vleeming; J G van Amsterdam; B H Stricker; D J de Wildt
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 6.  Adverse effects of angiotensin converting enzyme (ACE) inhibitors. An update.

Authors:  R C Parish; L J Miller
Journal:  Drug Saf       Date:  1992 Jan-Feb       Impact factor: 5.606

7.  Captopril: 4 years of post marketing surveillance of all patients in New Zealand.

Authors:  I R Edwards; D M Coulter; D M Beasley; D MacIntosh
Journal:  Br J Clin Pharmacol       Date:  1987-05       Impact factor: 4.335

8.  Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease.

Authors:  T C Slesnick; A R Mott; C D Fraser; A C Chang
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.838

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.